Suppression of Doxorubicin Cardiotoxicity by Overexpression of Catalase in the Heart of Transgenic Mice
Open Access
- 1 May 1996
- journal article
- Published by Elsevier BV in Online Journal of Public Health Informatics
- Vol. 271 (21), 12610-12616
- https://doi.org/10.1074/jbc.271.21.12610
Abstract
No abstract availableThis publication has 30 references indexed in Scilit:
- Extension of Life-Span by Overexpression of Superoxide Dismutase and Catalase in Drosophila melanogasterScience, 1994
- Genome scanning of higher eukaryotes by two-dimensional DNA typing using micro- and minisatellite core probesMethods, 1991
- The Isolated Mouse Atria as a New Model for Testing Cardioactive Drugs with Special Reference to Doxorubicin (Adriamycin®)Basic & Clinical Pharmacology & Toxicology, 1990
- Inhibition of doxorubicin-initiated membrane damage by N-acetylcysteine: Possible mediation by a thiol-dependent, cytosolic inhibitor of lipid peroxidationToxicology and Applied Pharmacology, 1988
- Role of catalase in metabolism of hydrogen peroxide by the perfused rat heartFEBS Letters, 1986
- Usefulness of a free radical scavenger in preventing doxorubicin-induced heart failure in dogsThe American Journal of Cardiology, 1985
- An electron spin resonance study of the reduction of peroxides by anthracycline semiquinonesBiochimica et Biophysica Acta (BBA) - General Subjects, 1984
- Mechanism of adriamycin cardiotoxicity: Evidence for oxidative stressLife Sciences, 1981
- The structure and evolution of the two nonallelic rat preproinsulin genesCell, 1979
- Adriamycin: The Role of Lipid Peroxidation in Cardiac Toxicity and Tumor ResponseScience, 1977